NCT07217938 2026-03-03
TRADstat
Peter MacCallum Cancer Centre, Australia
Phase 2 Recruiting
Clinical Trials
13 trialsNCT06912763 2026-01-26
Reversing External-beam Radiotherapy-associated Fibrosis Syndrome: an Interventional Bayesian Adaptive Randomized-controlled Orphan Drug Platform Trial for Orodental Sequelae (Reverse-fibrose)
M.D. Anderson Cancer Center
Phase 2 Recruiting
NCT04356209 2025-02-12
PRAVACUR-02
Institut du Cancer de Montpellier - Val d'Aurelle
Phase 2 Recruiting
NCT03127631 2025-01-31
RADICALPC
McMaster University
Phase NA Recruiting
NCT02484261 2023-03-15
Monitoring and Treatment of Relapsed Leukemia Following Allogeneic Hematopoietic Stem Cell Transplantation in Children
Children's National Research Institute
Phase 1 Terminated
NCT03219372 2021-01-22
Pravastatin Intervention to Delay Hepatocellular Carcinoma Recurrence
Cedars-Sinai Medical Center
Phase 2 Terminated
NCT01075555 2020-03-30
Sorafenib Tosylate With or Without Pravastatin in Treating Patients With Liver Cancer and Cirrhosis
Federation Francophone de Cancerologie Digestive
Phase 3 Completed
NCT01831232 2017-11-17
Idarubicin, Cytarabine, and Pravastatin Sodium in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes
Fred Hutchinson Cancer Center
Phase NA Completed
NCT01342887 2017-07-02
Cyclosporine, Pravastatin Sodium, Etoposide, and Mitoxantrone Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Fred Hutchinson Cancer Center
Phase 1/2 Terminated
NCT01357486 2017-05-01
PRODIGE 21
University Hospital, Bordeaux
Phase 2 Completed
NCT00433498 2014-12-03
Etoposide and Cisplatin or Carboplatin as First-Line Chemotherapy With or Without Pravastatin in Treating Patients With Small Cell Lung Cancer
University College, London
Phase 3 Completed
NCT01038154 2011-06-27
AGIM-1
Hospital Donostia
Phase 4 Unknown
NCT00107523 2010-09-21
Pravastatin, Idarubicin, and Cytarabine in Treating Patients With Acute Myeloid Leukemia
Fred Hutchinson Cancer Center
Phase 1 Completed